Phospholipase A2 in serum and colonic mucosa in ulcerative colitis

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 59, Issue 4, 1999, Pages 279-287

  Haapamäki, Markku M ^a   Gronroos J M ^a   Nurmi, H ^a   Irjala, K ^b   Alanen, K A ^a   Nevalainen, T J ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Endoscopy; Enzyme; Immunoassay; Inflammation; Inflammatory bowel disease

Indexed keywords

MESALAZINE; PHOSPHOLIPASE A2; PREDNISONE; SALAZOSULFAPYRIDINE; PHOSPHOLIPASE A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; DISEASE SEVERITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; MALE; PATHOGENESIS; PRIORITY JOURNAL; ULCERATIVE COLITIS; BLOOD; COLON; ENZYMOLOGY; EPITHELIUM CELL; INTESTINE MUCOSA; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; AGED; COLITIS, ULCERATIVE; COLON; EPITHELIAL CELLS; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PHOSPHOLIPASES A; PROSPECTIVE STUDIES;

EID: 0032588873     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519950185643     Document Type: Article

References (36)

1. 2(s); comparison of arachidonoyl-selective and -nonselective enzymes. Faseb J 1993; 7: 339-48.
2. 2 to phospholipid turnover and prostaglandin synthesis in mast-cell granules. Eur J Biochem 1991; 195: 707-13.
3. 2 - a mediator between proximal and distal effectors of inflammation. Immunol Today 1991; 12: 143-6.
4. 2 purified from an inflammatory exudate. Biochemistry 1986; 25: 8381-5.
5. 2. J Clin Invest 1995; 95: 603-10.
6. 2 acting against Escherichia coli. Infect Immun 1996; 64: 2425-30.
7. 2 based upon structural determinants. J Biol Chem 1977; 252: 4913-21.
8. 2 superfamily of signal transduction enzymes. Trends Biochem Sci 1997; 22: 1-2.
9. 2. J Biol Chem 1994; 269: 2365-8.
10. 2 is a major component of the salt-extractable pool of matrix proteins in adult human articular cartilage. Arthritis Rheum 1991; 34: 1106-15.
11. 2 in cartilage. J Rheumatol 1993; 20: 325-30.
12. 2 in human digestive organs. J Histochem Cytochem 1992; 40: 1659-64.
13. 2 in the human gastrointestinal tract. Lab Invest 1995; 72: 201-8.
14. 2 human seminal plasma. Andrologia 1993; 25: 355-8.
15. 2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991; 266: 2647-51.
16. 2 in inflammatory diseases. Clin Chem 1993; 39: 2453-9.
17. 2 protein in sera of patients with Crohn's disease and ulcerative colitis. Am J Gastroenterol 1993; 88: 1076-80.
18. 2 mass concentrations in serum and colonic mucosa in Crohn's disease. Clin Chem Lab Med 1998; 36: 751-5.
19. 2 in psoriatic tissue. Inflammation 1994; 18: 1-12.
20. 2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut 1994; 35: 1593-8.
21. 2 in intestine in ulcerative colitis. Gut 1997; 40: 95-101.
22. 2 in intestine in Crohn's disease. Am J Gastroenterol 1999: 94: 713-20.
23. 23 Blackstone MO. Inflammatory bowel disease. In Blackstone MO, editor. Endoscopic interpretation. New York: Raven Press, 1984: 475.
24. 24 Matts S. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961; 30: 393-407.
25. 2 in human serum. Clin Chem 1992; 38: 1824-9.
26. 26 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
27. 2 in serum in critically ill surgical patients. Crit Care Med 1994; 22: 956-9.
28. 2 in patients undergoing panproctocolectomy because of severe ulcerative colitis. Eur J Clin Chem Clin Biochem 1997; 35: 749-54.
29. 2 in colonic mucosa of patients with inflammatory bowel disease. Am J Gastroenterol 1997; 92: 289-92.
30. 2 in hepatocytes in a patient with epitheloid hemangioendothelioma of the liver. Lab Invest 1996; 74: 585-91.
31. 2 enzymes present in P388D1 macrophages. J Biol Chem 1996; 271: 6758-65.
32. 2. J Clin Invest 1996; 97: 250-7.
33. 33 Monajemi H, Meenan J, Lamping R, Obradov DO, Radema SA, Trown PW, et al. Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein. Gastroenterology 1996; 110: 733-9.
34. 34 Haapamäki MM, Häggblom J-O, Grönroos JM, Pekkala E, Alanen K, Nevalainen TJ. Bactericidal/ permeability-increasing protein in colonic mucosa in ulcerative colitis. Hepatogastroenterology. In press.
35. 2 gene expression in human hepatoma cells. Cytokine 1997; 9: 199-205.
36. 2) by sulfasalazine: a novel mechanism of anti-inflammatory activity. Biochem Pharmacol 1997; 53: 1901-7.